| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.43B | -2.1% |
| Cost of Revenue | $874.1M | +14.3% |
| Gross Profit | $555.4M | -20.2% |
| R&D Expense | $116.1M | -16.8% |
| SG&A Expense | $131.3M | +4.3% |
| Operating Income | $169.5M | -53.9% |
| Pre-tax Income | $183.4M | -50.0% |
| Income Tax | $72.6M | -18.1% |
| Net Income | $109.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $698.2M | -1.5% |
| Short-term Investments | $479.4M | -40.5% |
| Accounts Receivable | $211.3M | -19.4% |
| Inventory | $509.4M | +10.6% |
| Current Assets | $1.99B | -15.4% |
| Total Assets | $2.74B | -13.5% |
| Current Liabilities | $274.6M | -12.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $212.6M | -45.4% |
| Capital Expenditures | $110.1M | -10.5% |
| Investing Cash Flow | $297.0M | +171.3% |
| Financing Cash Flow | -$514.5M | -311.4% |
| Free Cash Flow | $102.5M | -61.5% |
| -60.5% |
| EPS (Basic) | $2.17 | -58.3% |
| EPS (Diluted) | $2.16 | -58.1% |
| Long-term Debt |
| $16.0M |
| -53.1% |
| Total Liabilities | $357.9M | -15.4% |
| Stockholders' Equity | $2.39B | -13.2% |